Skip to results
Modify your search
NARROW
1-20 of 81
Authors: Jean-Frederic Colombel
Journal Article
ACCEPTED MANUSCRIPT
Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Crohn’s Disease and Ulcerative Colitis: 2-Year Results from Open-Label Extensions of Two Randomized Controlled Trials (LIBERTY) Get access
Journal of Crohn's and Colitis, jjaf060, https://doi.org/10.1093/ecco-jcc/jjaf060
Published: 17 April 2025
Journal Article
Risankizumab efficacy and safety based on prior inadequate response or intolerance to advanced therapy: post hoc analysis of the INSPIRE and COMMAND phase 3 studies
Journal of Crohn's and Colitis, Volume 19, Issue 1, January 2025, jjaf005, https://doi.org/10.1093/ecco-jcc/jjaf005
Published: 13 January 2025
Journal Article
The Groupe d’Etude sur les Affections Inflammatoires Digestives (GETAID): 40 Years of a Family Story in Inflammatory Bowel Disease Get access
Journal of Crohn's and Colitis, Volume 19, Issue 2, February 2025, jjae122, https://doi.org/10.1093/ecco-jcc/jjae122
Published: 29 August 2024
Journal Article
Lemann Index for Assessing Bowel Damage in Crohn’s Disease: A Real-world Study Get access
Journal of Crohn's and Colitis, Volume 18, Issue 12, December 2024, Pages 1987–1994, https://doi.org/10.1093/ecco-jcc/jjae102
Published: 27 June 2024
Journal Article
Unravelling the Oral–Gut Axis: Interconnection Between Periodontitis and Inflammatory Bowel Disease, Current Challenges, and Future Perspective
Journal of Crohn's and Colitis, Volume 18, Issue 8, August 2024, Pages 1319–1341, https://doi.org/10.1093/ecco-jcc/jjae028
Published: 28 February 2024
Journal Article
Efficacy and Safety of Filgotinib for the Treatment of Perianal Fistulising Crohn’s Disease [DIVERGENCE 2]: A Phase 2, Randomised, Placebo-controlled Trial
Journal of Crohn's and Colitis, Volume 18, Issue 6, June 2024, Pages 864–874, https://doi.org/10.1093/ecco-jcc/jjae003
Published: 16 February 2024
Journal Article
Risankizumab Induction Therapy Achieves Early Symptom Improvements That Are Associated With Future Clinical and Endoscopic Outcomes in Crohn’s Disease: Post Hoc Analysis of the ADVANCE, MOTIVATE, and FORTIFY Phase 3 Studies
Journal of Crohn's and Colitis, Volume 18, Issue 6, June 2024, Pages 818–827, https://doi.org/10.1093/ecco-jcc/jjad206
Published: 09 December 2023
Journal Article
The Safety, Tolerability, Pharmacokinetics, and Clinical Efficacy of the NLRX1 agonist NX-13 in Active Ulcerative Colitis: Results of a Phase 1b Study
Journal of Crohn's and Colitis, Volume 18, Issue 5, May 2024, Pages 762–772, https://doi.org/10.1093/ecco-jcc/jjad192
Published: 11 November 2023
Journal Article
Human Leukocyte Antigen Signatures as Pathophysiological Discriminants of Microscopic Colitis Subtypes
Journal of Crohn's and Colitis, Volume 18, Issue 3, March 2024, Pages 349–359, https://doi.org/10.1093/ecco-jcc/jjad165
Published: 28 September 2023
Journal Article
Efficacy and Safety of Approximately 3 Years of Continuous Ozanimod in Moderately to Severely Active Ulcerative Colitis: Interim Analysis of the True North Open-label Extension
Journal of Crohn's and Colitis, Volume 18, Issue 2, February 2024, Pages 264–274, https://doi.org/10.1093/ecco-jcc/jjad146
Published: 31 August 2023
Journal Article
Lémman Index in Children: Still an Open Question
Journal of Crohn's and Colitis, Volume 18, Issue 2, February 2024, Pages 331–332, https://doi.org/10.1093/ecco-jcc/jjad137
Published: 10 August 2023
Journal Article
Influence of Early Life Factors, including breast milk Composition, on the Microbiome of Infants Born to Mothers with and without Inflammatory Bowel Disease
Journal of Crohn's and Colitis, Volume 17, Issue 11, November 2023, Pages 1723–1732, https://doi.org/10.1093/ecco-jcc/jjad096
Published: 06 June 2023
Journal Article
Risk Factors for Developing Inflammatory Bowel Disease Within and Across Families with a Family History of IBD
Journal of Crohn's and Colitis, Volume 17, Issue 1, January 2023, Pages 30–36, https://doi.org/10.1093/ecco-jcc/jjac111
Published: 09 August 2022
Journal Article
Impact of COVID-19 on Healthcare Resource Utilisation Among Patients with Inflammatory Bowel Disease in the USA
Journal of Crohn's and Colitis, Volume 16, Issue 9, September 2022, Pages 1405–1414, https://doi.org/10.1093/ecco-jcc/jjac056
Published: 09 April 2022
Journal Article
Categorising Endoscopic Severity of Crohn’s Disease Using the Modified Multiplier SES-CD [MM-SES-CD]
Journal of Crohn's and Colitis, Volume 16, Issue 7, July 2022, Pages 1011–1019, https://doi.org/10.1093/ecco-jcc/jjac018
Published: 03 February 2022
Journal Article
Early Reduction in MM-SES-CD Score After Initiation of Biologic Therapy is Highly Specific for 1-year Endoscopic Remission in Moderate to Severe Crohn’s Disease
Journal of Crohn's and Colitis, Volume 16, Issue 4, April 2022, Pages 616–624, https://doi.org/10.1093/ecco-jcc/jjab183
Published: 19 October 2021
Journal Article
Inflammatory Bowel Disease Clinical Activity is Associated with COVID-19 Severity Especially in Younger Patients
Journal of Crohn's and Colitis, Volume 16, Issue 4, April 2022, Pages 591–600, https://doi.org/10.1093/ecco-jcc/jjab172
Published: 27 September 2021
Journal Article
The Impact of Vedolizumab on COVID-19 Outcomes Among Adult IBD Patients in the SECURE-IBD Registry
Journal of Crohn's and Colitis, Volume 15, Issue 11, November 2021, Pages 1877–1884, https://doi.org/10.1093/ecco-jcc/jjab071
Published: 21 April 2021
Journal Article
Efficacy and Safety of Tofacitinib Re-treatment for Ulcerative Colitis After Treatment Interruption: Results from the OCTAVE Clinical Trials
Journal of Crohn's and Colitis, Volume 15, Issue 11, November 2021, Pages 1852–1863, https://doi.org/10.1093/ecco-jcc/jjab065
Published: 21 April 2021
Journal Article
Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD—Prediction and Prevention of Inflammatory Bowel Disease
Journal of Crohn's and Colitis, Volume 15, Issue 9, September 2021, Pages 1443–1454, https://doi.org/10.1093/ecco-jcc/jjab048
Published: 17 March 2021
